TY - JOUR
T1 - Evidence of macular pigment in the central macula in albinism
AU - Wolfson, Yulia
AU - Fletcher, Emily
AU - Strauss, Rupert W.
AU - Scholl, Hendrik P.N.
N1 - Publisher Copyright:
© 2015 Elsevier Ltd.
PY - 2016/4/1
Y1 - 2016/4/1
N2 - Purpose: Albinism represents a spectrum of disorders with diminished to absent amounts of melanin pigmentation including the posterior segment of the eye. Macular pigment (MP) consists of two main carotenoids, lutein and zeaxanthin, concentrated in the macula. MP serves as blue light absorbent, antioxidant, and may reduce chromatic aberration and glare. It remains unclear if albinos have detectable MP. The purpose was to investigate the distribution of MP in albino patients with psychophysical and imaging techniques. Methods: MP was measured at the eccentricity of 0.5° by heterochromatic flicker perimetry (QuantifEye®; Tinsley Precision Instruments Ltd.) or by scanning laser ophthalmoscopy (MPOD module, MultiColor Spectralis®, Heidelberg Engineering, Heidelberg, Germany) in four albino patients, who were also investigated with multimodal ophthalmic imaging. Results: Visual acuity ranged from 20/32 to 20/125, nystagmus was present in three patients, and all patients showed typical foveal hypoplasia on fundus exam and optical coherence tomography. Fundus autofluorescence (FAF) demonstrated various degrees of central FAF signal attenuation. Genetic testing was available in three patients and confirmed the diagnosis. Measurable amounts of MP were detected in all four patients and ranged from 0.05 to 0.24, which is below the normal range. Conclusions: We conclude that MP can be demonstrated and measured in albinos. Further studies are needed to investigate MP accumulation following carotenoid supplementation and its impact on visual performance.
AB - Purpose: Albinism represents a spectrum of disorders with diminished to absent amounts of melanin pigmentation including the posterior segment of the eye. Macular pigment (MP) consists of two main carotenoids, lutein and zeaxanthin, concentrated in the macula. MP serves as blue light absorbent, antioxidant, and may reduce chromatic aberration and glare. It remains unclear if albinos have detectable MP. The purpose was to investigate the distribution of MP in albino patients with psychophysical and imaging techniques. Methods: MP was measured at the eccentricity of 0.5° by heterochromatic flicker perimetry (QuantifEye®; Tinsley Precision Instruments Ltd.) or by scanning laser ophthalmoscopy (MPOD module, MultiColor Spectralis®, Heidelberg Engineering, Heidelberg, Germany) in four albino patients, who were also investigated with multimodal ophthalmic imaging. Results: Visual acuity ranged from 20/32 to 20/125, nystagmus was present in three patients, and all patients showed typical foveal hypoplasia on fundus exam and optical coherence tomography. Fundus autofluorescence (FAF) demonstrated various degrees of central FAF signal attenuation. Genetic testing was available in three patients and confirmed the diagnosis. Measurable amounts of MP were detected in all four patients and ranged from 0.05 to 0.24, which is below the normal range. Conclusions: We conclude that MP can be demonstrated and measured in albinos. Further studies are needed to investigate MP accumulation following carotenoid supplementation and its impact on visual performance.
KW - Albinism
KW - Diet supplementation
KW - Foveal hypoplasia
KW - Lutein
KW - Macular pigment
KW - Zeaxanthin
UR - http://www.scopus.com/inward/record.url?scp=84951027759&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84951027759&partnerID=8YFLogxK
U2 - 10.1016/j.exer.2015.10.006
DO - 10.1016/j.exer.2015.10.006
M3 - Article
C2 - 26474496
AN - SCOPUS:84951027759
SN - 0014-4835
VL - 145
SP - 468
EP - 471
JO - Experimental eye research
JF - Experimental eye research
ER -